Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 12 May 2006:
Vol. 312. no. 5775, pp. 851 - 852
DOI: 10.1126/science.1128827
Prev | Table of Contents | Next

Policy Forum

PUBLIC HEALTH:
Progress Toward Rotavirus Vaccines

Umesh D. Parashar1* and Roger I. Glass1

New childhood vaccines against rotavirus could prevent a leading cause of death among children in the developing world and do not have the dangerous side effects of the previous version.

1The authors are in the Viral Gastroenteritis Section, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA.

*Author for correspondence. E-mail: uap2{at}cdc.gov

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
The Burden of Rotavirus Hospitalizations Among Medicaid and Non-Medicaid Children Younger Than 5 Years Old.
L. Ma, A. C. El Khoury, and R. F. Itzler (2009)
Am J Public Health 99, S398-S404
   Abstract »    Full Text »    PDF »
Public health impact and cost effectiveness of mass vaccination with live attenuated human rotavirus vaccine (RIX4414) in India: model based analysis.
J. Rose, R. L Hawthorn, B. Watts, and M. E Singer (2009)
BMJ 339, b3653
   Abstract »    Full Text »    PDF »
Association of Gamma Interferon and Interleukin-17 Production in Intestinal CD4+ T Cells with Protection against Rotavirus Shedding in Mice Intranasally Immunized with VP6 and the Adjuvant LT(R192G).
K. L. Smiley, M. M. McNeal, M. Basu, A. H.-C. Choi, J. D. Clements, and R. L. Ward (2007)
J. Virol. 81, 3740-3748
   Abstract »    Full Text »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)